References
- DoroudDZahedifardFGholamiECationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluationsJ Pharm Pharm Sci20101332033521092706
- NagarajSPisarevVKinarskyLDendritic cell-based full-length survivin vaccine in treatment of experimental tumorsJ Immunother20073016917917471164
- IdenoueSHirohashiYTorigoeTA potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteinsClin Cancer Res2005111474148215746049
- ReedJCCancer immunotherapy targeting survivinClin Cancer Res200396523653314695157
- YaoXYoshiokaYMorishigeTSystemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasisGene Ther2009161395140419641532
- Cavazzana-CalvoMThrasherAMavilioFThe future of gene therapyNature200442777978114985734
- World Health OrganizationThe global burden of disease: 2004 updateGeneva, SwitzerlandWorld Health Organization2008
- JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin20116699021296855
- JemalAMurrayTWardECancer statisticsCA Cancer J Clin200555103015661684
- HuertaSEmilyJEdwardHColon cancer and apoptosisAm J Surg200619151752616531147
- RyanBMO’DonovanNDuffyMJSurvivin: A new target for anti-cancer therapyCancer Treat Rev20093555356219559538
- HarikumarKBAggarwalBBResveratrol: a multitargeted agent for age associated chronic diseasesCell Cycle2008781020103518414053
- YangYXGaoYChenLLDownregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticlesInt J Pharm201140518819521130850
- LiFZAmbrosiniGChuEYControl of apoptosis and mitotic spindle checkpoint by survivinNature19983965805849859993
- SharifiNQiJBaneSSurvivin is not induced by novel taxanesMol Pharm201072216222320863081
- PengXCYangLYangLPEfficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34→Ala mutantJ Exp Clin Cancer Res2008274618816410
- ShanYWangCTYangLInhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administrationJ Biosci20103520921620689177
- PanLPengXCLengFTherapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancerJ Cancer Res Clin Oncol2011137192820217127
- OhlfestJRFreeseABLargaespadaDANonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapiesCurr Gene Ther2005562964116457652
- ItoTYoshiharaCHamadaKDNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in miceBiomaterials2010312912291820047759
- FujitaTFuruhataMHattoriYHigh gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNAJ Control Release200812912412718513820
- BrownMDSchätzleinAGUchegbuIFGene delivery with synthetic (non viral) carriersInt J Pharm200122912111604253
- KimTHParkIKNahJWGalactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrierBiomaterials20032537893792
- ParkTGJeongJHKimSWCurrent status of polymeric gene delivery systemsAdv Drug Deliv Rev20065846748616781003
- ZengXSunYXQuWBiotinylated transferrin/avidin/biotinylated disulfide containing PEI bioconjugates mediated p53 gene delivery system for tumor targeted transfectionBiomaterials2010314771478020219242
- Henriksen-LaceyMChristensenDBramwellVWLiposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI responseJ Control Release201014510210820381556
- WaltherWSteinUVossCStability analysis for long-term storage of naked DNA: impact on nonviral in vivo gene transferAnal Biochem200331823023512814626
- LiangBHeMLChanCYThe use of folate-PEG-grafted-hybranched- PEI nonviral vector for the inhibition of glioma growth in the ratBiomaterials2009304014402019427690
- GouMLMenKZhangJAEfficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimineACS Nano201045573558420839784
- FoillardSZuberGDorisEPolyethylenimine-carbon nanotube nano-hybrids for siRNA-mediated gene silencing at cellular levelNanoscale201131461146421301705
- FengLZhangSLiuZGraphene based gene transfectionNanoscale201131252125721270989
- GouMMenKShiHCurcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivoNanoscale201131558156721283869
- WangXYangLChenZShinDMApplication of nanotechnology in cancer therapy and imagingCA Cancer J Clin2008589711018227410
- KievitFMVeisehOFangCChlorotoxin labeled magnetic nanovectors for targeted gene delivery to gliomaACS Nano201044587459420731441
- PatilMLZhangMMinkoTMultifunctional triblock nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencingACS Nano201151877188721322531
- ZhangJSunHMaPXHost-guest interaction mediated polymeric assemblies: multifunctional nanoparticles for drug and gene deliveryACS Nano201041049105920112968
- ItakaKKataokaKRecent development of nonviral gene delivery systems with virus-like structures and mechanismsEur J Pharm Biopharm20097147548318955136
- HashemiMParhizBHHatefiARamezaniMModified polyethyleneimine with histidine-lysine short peptides as gene carrierCancer Gene Ther201118121920930861
- ParkJWBaeKHKimCClustered magnetite nanocrystals cross-linked with PEI for efficient siRNA deliveryBiomacromolecules20111245746521190334
- ChoiYKimCWAntitumor effects of combined granulocyte macrophage colony stimulating factor and macrophage inflammatory protein-3 alpha plasmid DNACancer Sci20101012341235020804501
- GantaSShahiwalaAAmijiMA review of stimuli-responsive nanocarriers for drug and gene deliveryJ Control Release200812618720418261822
- LiSDHuangLNon-viral is superior to viral gene deliveryJ Control Release200712318118317935817
- JoshiMDMullerRHLipid nanoparticles for parenteral delivery of activesEur J Pharm Biopharm20097116117218824097
- CanineBFHatefiADevelopment of recombinant cationic polymers for gene therapy researchAdv Drug Deliv Rev2010621524152920399239
- KlinkDSchindelhauerDLanerAGene delivery systems – gene therapy vectors for cystic fibrosisJ Cyst Fibros2004320321215463959
- BakerAHDesigning gene delivery vectors for cardiovascular gene therapyProg Biophys Mol Biol20048427929914769440
- MorilleMPassiraniCVonarbourgAProgress in developing cationic vectors for non-viral systemic gene therapy against cancerBiomaterials2008293477349618499247
- ZhouXLiXGouMAntitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasisCancer Sci20111021403140921564417
- WeiYQWangQRZhaoXImmunotherapy of tumors with xenogeneic endothelial cells as a vaccineNat Med200061160116611017149
- O’ConnorDSSchechnerJSAdidaCControl of apoptosis during angiogenesis by survivin expression in endothelial cellsAm J Pathol200015639339810666367
- WilsonAJChuehACTögelLApoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene inductionCancer Res20107060962020068171
- YodkeereeSSungBLimtrakulPAggarwalBBZerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: evidence for an essential role of reactive oxygen speciesCancer Res2009696581658919654295
- Sartore-BianchiAMartiniMMolinariFPIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodiesCancer Res2009691851185719223544
- LiHJEvertsMYamamotoMCurielDTHerschmanHRCombined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumorsCancer Res20096955456419147569
- O’ConnorDSGrossmanDPlesciaJRegulation of apoptosis at cell division by p34cdc2 phosphorylation of survivinProc Natl Acad Sci U S A200097131031310711069302
- AltieriDCValidating survivin as a cancer therapeutic targetNat Rev Cancer20033465412509766
- BhatnagarNLiXChenYZhouXGarrettSHGuoB3,3′-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivinCancer Prev Res20092581589